Could serum S100B be a predictor of neuronal damage and clinical poor outcomes associated with the use of synthetic cannabinoids? S100B to predict neuronal damage of SC in the ED

YILMAZ, SERKAN; Karakayali, Onur; Kale, Ebru; Akdogan, Ahmet

doi:10.1016/j.ajem.2017.08.053

Could serum S100B be a predictor of neuronal damage and clinical poor outcomes associated with the use of synthetic cannabinoids? S100B to predict neuronal damage of SC in the ED

YILMAZ S. , Karakayali O., Kale E., Akdogan A.

AMERICAN JOURNAL OF EMERGENCY MEDICINE, vol.36, no.3, pp.435-441, 2018 (Journal Indexed in SCI)

Publication Type: Article / Article
Volume: 36 Issue: 3
Publication Date: 2018
Doi Number: 10.1016/j.ajem.2017.08.053
Title of Journal : AMERICAN JOURNAL OF EMERGENCY MEDICINE
Page Numbers: pp.435-441

Abstract

Aim: This study aims to evaluate the serum S100B levels to predict neuronal damage and poor clinical outcomes associated with the use of synthetic cannabinoids.